Fragmented and Poorly Executed- the Failed Potential of mRNA Vaccine Therapeutic Platform

Aditi Bhargava
9 min readFeb 19, 2023

It has taken Pfizer nearly 2 years to publish a paper showing any data regarding whether the mRNA is actually made into a protein product. Two years!!! This work should have been available before the emergency use authorization (EUA) was granted for the vaccines. Unfortunately, none of the basic bench-to-bedside work was submitted for…

--

--

Aditi Bhargava

Dr. Aditi Bhargava is a molecular neuroendocrinologist with research focus on sex differences in stress biology and immunology.